chrX-153506051-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001711.6(BGN):​c.540C>T​(p.Ser180Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.454 in 1,208,518 control chromosomes in the GnomAD database, including 86,306 homozygotes. There are 179,722 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 6137 hom., 12295 hem., cov: 23)
Exomes 𝑓: 0.46 ( 80169 hom. 167427 hem. )

Consequence

BGN
NM_001711.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -6.58

Publications

23 publications found
Variant links:
Genes affected
BGN (HGNC:1044): (biglycan) This gene encodes a member of the small leucine-rich proteoglycan (SLRP) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein, which plays a role in bone growth, muscle development and regeneration, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity. Additionally, the encoded protein may contribute to atherosclerosis and aortic valve stenosis in human patients. This gene and the related gene decorin are thought to be the result of a gene duplication. [provided by RefSeq, Nov 2015]
BGN Gene-Disease associations (from GenCC):
  • Meester-Loeys syndrome
    Inheritance: XL Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Illumina, G2P
  • X-linked spondyloepimetaphyseal dysplasia
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant X-153506051-C-T is Benign according to our data. Variant chrX-153506051-C-T is described in ClinVar as Benign. ClinVar VariationId is 1166521.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.58 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.473 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BGNNM_001711.6 linkc.540C>T p.Ser180Ser synonymous_variant Exon 4 of 8 ENST00000331595.9 NP_001702.1 P21810B4DNL4
BGNXM_017029724.3 linkc.540C>T p.Ser180Ser synonymous_variant Exon 3 of 7 XP_016885213.1 P21810

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BGNENST00000331595.9 linkc.540C>T p.Ser180Ser synonymous_variant Exon 4 of 8 1 NM_001711.6 ENSP00000327336.4 P21810

Frequencies

GnomAD3 genomes
AF:
0.371
AC:
41275
AN:
111200
Hom.:
6140
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.154
Gnomad AMI
AF:
0.358
Gnomad AMR
AF:
0.395
Gnomad ASJ
AF:
0.393
Gnomad EAS
AF:
0.428
Gnomad SAS
AF:
0.388
Gnomad FIN
AF:
0.452
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.477
Gnomad OTH
AF:
0.374
GnomAD2 exomes
AF:
0.426
AC:
77501
AN:
181856
AF XY:
0.434
show subpopulations
Gnomad AFR exome
AF:
0.148
Gnomad AMR exome
AF:
0.378
Gnomad ASJ exome
AF:
0.387
Gnomad EAS exome
AF:
0.452
Gnomad FIN exome
AF:
0.474
Gnomad NFE exome
AF:
0.479
Gnomad OTH exome
AF:
0.442
GnomAD4 exome
AF:
0.462
AC:
507411
AN:
1097267
Hom.:
80169
Cov.:
37
AF XY:
0.462
AC XY:
167427
AN XY:
362771
show subpopulations
African (AFR)
AF:
0.145
AC:
3828
AN:
26391
American (AMR)
AF:
0.375
AC:
13182
AN:
35142
Ashkenazi Jewish (ASJ)
AF:
0.394
AC:
7639
AN:
19380
East Asian (EAS)
AF:
0.387
AC:
11680
AN:
30195
South Asian (SAS)
AF:
0.410
AC:
22208
AN:
54125
European-Finnish (FIN)
AF:
0.461
AC:
18556
AN:
40217
Middle Eastern (MID)
AF:
0.437
AC:
1809
AN:
4135
European-Non Finnish (NFE)
AF:
0.485
AC:
408120
AN:
841617
Other (OTH)
AF:
0.443
AC:
20389
AN:
46065
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
10776
21552
32327
43103
53879
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13194
26388
39582
52776
65970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.371
AC:
41262
AN:
111251
Hom.:
6137
Cov.:
23
AF XY:
0.367
AC XY:
12295
AN XY:
33477
show subpopulations
African (AFR)
AF:
0.154
AC:
4733
AN:
30766
American (AMR)
AF:
0.395
AC:
4185
AN:
10605
Ashkenazi Jewish (ASJ)
AF:
0.393
AC:
1039
AN:
2641
East Asian (EAS)
AF:
0.428
AC:
1491
AN:
3487
South Asian (SAS)
AF:
0.387
AC:
1006
AN:
2602
European-Finnish (FIN)
AF:
0.452
AC:
2686
AN:
5947
Middle Eastern (MID)
AF:
0.512
AC:
111
AN:
217
European-Non Finnish (NFE)
AF:
0.478
AC:
25213
AN:
52798
Other (OTH)
AF:
0.368
AC:
557
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
884
1768
2652
3536
4420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.443
Hom.:
32302
Bravo
AF:
0.359

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25173489) -

not specified Benign:1
Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

X-linked spondyloepimetaphyseal dysplasia Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meester-Loeys syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Dec 04, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
1.0
DANN
Benign
0.81
PhyloP100
-6.6
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1126499; hg19: chrX-152771509; COSMIC: COSV59037216; API